Internal Medicine, Hematology & Oncology · Fajardo, PR
NPI
1366574725
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
Ave. General Valero 410, Torre San Pablo del Este Suite 205
Fajardo, PR, 00738
Phone (787) 655-4060
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,176
96 services
Medicare patients, 2024
23
Average age 78
Drug cost, 2024
$4.0M
2,628 prescriptions
Company payments, 2025
$1,054
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Carlos M Tejeda was code 99213 (office e&m - established), 50 times for 22 patients. In total Carlos M Tejeda billed 96 services in 9 codes, and Medicare paid $4,176.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 50 | 22 | $53.66 | $2,683 |
By year: 2022 $5,152 for 97 services; 2023 $4,043 for 71 services; 2024 $4,176 for 96 services.
Medicare prescription drug claims, 2024
In 2024, the drug Carlos M Tejeda prescribed most often to Medicare patients was Anastrozole, with 407 prescriptions and refills. In total Carlos M Tejeda wrote 2,628 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 407 | 467 | 70 | $5,455 |
| Famotidine Generic | 187 | 215 | 53 | $1,294 |
| Ondansetron Hcl Generic | 118 | 118 | 25 | $577 |
| Dexamethasone Generic | 111 | 111 | 22 | $1,175 |
| Metoclopramide Hcl Generic | 89 | 90 | 22 | $312 |
| Warfarin Sodium Generic | 78 | 80 | Under 11 | $517 |
| Prednisone Generic | 74 | 80 | 18 | $597 |
| Hydroxyurea Generic | 71 | 73 | 12 | $1,801 |
| Tamoxifen Citrate Generic | 69 | 75 | 12 | $1,384 |
| Dexamethasone Sodium Phosphate Generic | 66 | 72 | Under 11 | $228 |
| Tamsulosin Hcl Generic | 66 | 76 | 15 | $564 |
| Retacrit Epoetin Alfa-Epbx | 64 | 65 | 44 | $76K |
| Ondansetron Hcl Ondansetron Hcl/Pf | 60 | 60 | Under 11 | $220 |
| Famotidine Famotidine/Pf | 56 | 56 | Under 11 | $206 |
| Bicalutamide Generic | 56 | 64 | 18 | $1,842 |
Brand drugs: 579 claims; generic drugs: 2,049 claims; opioid claims: 34.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Carlos M Tejeda $1,054 ($1,054 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $206.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 12 | $206 |
| Merck Sharp & Dohme LLC MRK | 5 | $117 |
| Fennec Pharmaceuticals, Inc. FENC | 2 | $116 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $116 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $100 |
| Eli Lilly Export S.A. Puerto Rico Branch LLY | 3 | $67.76 |
| PharmaEssentia USA Corporation 6446.TW | 2 | $55.92 |
| Sobi, Inc SOBI.ST | 2 | $50 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $50 |
| BeOne Medicines USA, Inc. ONC | 2 | $49.53 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.